1,8-Diazabicyclo(5.4.0)undec-7-ene → 3-[(7-fluoroimidazo[1,2-a]quinoxalin-4-yl)amino]propyl (2R)-2-[(tert-butoxycarbonyl)amino]propanoate

HRID 1893494

반응식

HRID 1893494 반응식
[F:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]1[CH:12]=[CH:13][N:14]=[C:7]1[C:6]([NH:15][CH2:16][CH2:17][CH2:18][OH:19])=[N:5]2.N12CCCN=C1CCCCC2.O=C1CCC(=O)N1[O:38][C:39](=O)[C@H:40]([NH:42][C:43](=[O:49])[O:44][C:45]([CH3:48])([CH3:47])[CH3:46])[CH3:41]>CN(C)C=O.O>[C:45]([O:44][C:43]([NH:42][C@H:40]([CH3:41])[C:39]([O:19][CH2:18][CH2:17][CH2:16][NH:15][C:6]1[C:7]2[N:8]([CH:12]=[CH:13][N:14]=2)[C:9]2[C:4]([N:5]=1)=[CH:3][C:2]([F:1])=[CH:11][CH:10]=2)=[O:38])=[O:49])([CH3:48])([CH3:47])[CH3:46]

참가 물질

6

반응 조건

온도
60 °C

실험 절차

To a solution of commercially available (Peakdale) 3-[(7-fluoroimidazo[1,2-a]quinoxalin-4-yl)amino]propan-1-ol (20 mg, 0.08 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (12 μL, 0.08 mmol) in anhydrous dimethylformamide (600 μL) under argon was added dropwise a solution of tert-butyl {(1R)-2-[(2,5-dioxopyrrolidin-1-yl)oxy]-1-methyl-2-oxoethyl}carbamate (22 mg, 0.08 mmol) in anhydrous dimethylformamide (200 μL). The mixture was stirred at 60° C. for 65 h, then diluted with cold water and extracted four times with chloroform and once with chloroform/isopropanol (5:1). The combined organic layers were washed with brine, dried over sodium sulfate, filtered and evaporated. The crude product was purified by preparative TLC (silica, dichloromethane/methanol 20/1) to afford the title compound as a colorless oil (4 mg, 12%).

후처리

  1. extractionextracted four times with chloroform
  2. washThe combined organic layers were washed with brine
  3. dry with materialdried over sodium sulfate
  4. filtrationfiltered
  5. customevaporated
  6. customThe crude product was purified by preparative TLC (silica, dichloromethane/methanol 20/1)

출처 및 근거

ORD 기록
ord-84aa437415f64c03aef66361a8453af1
출처 데이터셋
uspto-grants-2013_08
특허 번호
US08513250B2

연결된 노트

불러오는 중…